Aryl Hydrocarbon Receptor Antagonist
Showing 1 - 25 of 8,020
Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Cancer Trial in United States (IK-175 + nivolumab)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +5 more
- IK-175 + nivolumab
-
Chicago, Illinois
- +3 more
Jul 26, 2022
Tryptophan Metabolism Alterations, Celiac Disease Trial (L-Tryptophan, L-Leucine)
Not yet recruiting
- Tryptophan Metabolism Alterations
- Celiac Disease
- (no location specified)
Oct 14, 2022
Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)
Recruiting
- Urothelial Carcinoma
- +20 more
- IK-175
- IK-175 and nivolumab
-
Gilbert, Arizona
- +9 more
Feb 3, 2022
Kynurenine/Tryptophan Ratio in Hypertension Associated to
Recruiting
- Hypertension Secondary
-
Lisboa, Portugal
- +4 more
Mar 15, 2022
Endometriosis, Infertility Unexplained Trial in Krakow (Detection of PAHs in visceral fat with gas chromatography-isotope
Recruiting
- Endometriosis
- Infertility Unexplained
- Detection of PAHs in visceral fat with gas chromatography-isotope dilution mass spectrometry
-
Krakow, PolandJagiellonian University Medical College, Department of Gynecolog
Mar 16, 2023
ICD10 Code L40.9 for Psoriasis Trial in Winston-Salem (Betamethasone dipropionate 0.05%, Tapinarof)
Not yet recruiting
- ICD10 Code L40.9 for Psoriasis
- Betamethasone dipropionate 0.05%
- Tapinarof
-
Winston-Salem, North CarolinaWake Forest University Health Sciences Department of Dermatology
Jul 31, 2023
Genetics of Endocrine Tumours - Familial Isolated Pituitary
Recruiting
- Acromegaly
- +5 more
-
London, United Kingdom
- +1 more
Oct 17, 2022
PONV in Laparoscopic Cholocystectomies Trial in Larissa (Dimenhydrinate Tablets, Ondansetron iv)
Completed
- PONV in Laparoscopic Cholocystectomies
- Dimenhydrinate Tablets
- Ondansetron iv
-
Larissa, Thessaly, GreeceUniversity Hospital of Larisa, Department of Anesthesiology
Dec 7, 2022
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR
Not yet recruiting
- Pericarditis
- IL1RA Antibody Assay
- suPAR Testing
-
Homburg, Germany
- +8 more
Jun 22, 2023
Preemptive Analgesia, Dexmedetomidine, Ketamine Trial in Kafr Ash Shaykh (Dexmedetomidine, Ketamine, Magnesium sulphate)
Not yet recruiting
- Preemptive Analgesia
- +5 more
- Dexmedetomidine
- +2 more
-
Kafr Ash Shaykh, Karelsheikh, EgyptKarelsheikh University Hospital
Apr 19, 2023
Opioid-Induced Constipation Trial in Leuven (Naloxegol, codeine phosphate, Placebo)
Completed
- Opioid-Induced Constipation
- Naloxegol
- +2 more
-
Leuven, Vlaams-Brabant, BelgiumUZ Leuven
Mar 15, 2023
Healthy Volunteers Trial in Baltimore (PC14586, Rabeprazole, Famotidine)
Not yet recruiting
- Healthy Volunteers
- PC14586
- +2 more
-
Baltimore, MarylandParexel International
Sep 19, 2023
Monitoring Drug Efficacy in Patients With Alzheimer's Disease
Recruiting
- Alzheimer Disease
- AChE inhibitor monotherapy
- AChE inhibitor and NMDA receptor antagonist combination therapy
-
Manila, Metro Manila, PhilippinesPhilippine General Hospital
Mar 24, 2023
Renin Angiotensin Aldosterone System Genetic Polymorphism on
Recruiting
- Myocardial Infarction
-
Cairo, EgyptAin Shams University
May 16, 2023
LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)
Not yet recruiting
- LARS - Low Anterior Resection Syndrome
-
Seoul, Jongro-gu, Korea, Republic ofSeoul National University Hospital
Dec 13, 2022
Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
- Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 4, 2023
Neuroendocrine Tumors Trial in Beijing, Fuzhou (Gallium-68 NODAGA-JR11)
Recruiting
- Neuroendocrine Tumors
- Gallium-68 NODAGA-JR11
-
Beijing, Beijing, China
- +1 more
Jul 27, 2022
Cushing Syndrome, Cushing Disease, Ectopic ACTH Syndrome Trial run by the Crinetics Pharmaceuticals Inc. (CRN04894)
Recruiting
- Cushing Syndrome
- +2 more
-
Bethesda, MarylandNational Institutes of Health (NIH) - National Institute of Diab
Mar 27, 2023
Advanced Malignant Tumor Trial in Guangzhou, Zhengzhou, Nanjing (TQB3915 tablets)
Recruiting
- Advanced Malignant Tumor
- TQB3915 tablets
-
Guangzhou, Guangdong, China
- +2 more
Jun 9, 2022
Cornea Ulcer Trial in Minya (Naltrexone Hydrochloride, Carboxy methyl cellulose)
Completed
- Cornea Ulcer
- Naltrexone Hydrochloride
- Carboxy methyl cellulose
-
Minya, EgyptFaculty of Medicine
Jun 20, 2023
Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)
Not yet recruiting
- Depressive Disorder, Major
- Anxiety Disorder
- Nociceptin Receptor Antagonist
- Aversive stimuli
- (no location specified)
Nov 3, 2022
Postoperative Shivering Trial in Islamabad (Dexmedetomidine, Ketamine)
Completed
- Postoperative Shivering
-
Islamabad, Federal, PakistanPAF Hospital Islamabad
Feb 6, 2023